Loading…

Charge Transfer Complexes of the Donor Acriflavine and the Acceptors Quinol, Picric acid, TCNQ and DDQ: Synthesis, Spectroscopic Characterizations and Antimicrobial Studies

Four new charge-transfer (CT) complexes have been formed in the reaction of the topical antiseptic agent acriflavine (Acf) with the acceptors quinol (QL), picric acid (PA), tetracyanoquinodimethane (TCNQ) and dichlorodicyanobenzoquinone (DDQ). The reactions have been studied spectrophotometrically i...

Full description

Saved in:
Bibliographic Details
Published in:International journal of electrochemical science 2013-04, Vol.8 (4), p.5774-5800
Main Authors: Eldaroti, Hala H., Gadir, Suad A., Refat, Moamen S., Adam, Abdel Majid A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Four new charge-transfer (CT) complexes have been formed in the reaction of the topical antiseptic agent acriflavine (Acf) with the acceptors quinol (QL), picric acid (PA), tetracyanoquinodimethane (TCNQ) and dichlorodicyanobenzoquinone (DDQ). The reactions have been studied spectrophotometrically in methanol and the formed solid complexes were isolated and characterized through elemental analysis, electronic absorption, spectrophotometric titration, IR, Raman, 1H-NMR and X-ray powder diffraction (XRD) techniques as well as thermal analysis and scanning electron microscopy (SEM). The reaction stoichiometries, donor: acceptor molar ratio values, were found to be 1:2 ratio for QL and PA complexes and 1:1 ratio for TCNQ and DDQ complexes. Accordingly the formed CT complexes could be formulated as [(Acf)(QL)2], [(Acf)(PA)2], [(Acf)(TCNQ)] and [(Acf)(DDQ)]. Finally, the CT complexes were screened for their antibacterial and antifungal activities against various bacterial and fungal strains, and the complex obtained using QL acceptor exhibited good antimicrobial activities against all of the tested strains compared with standard drugs.
ISSN:1452-3981
1452-3981
DOI:10.1016/S1452-3981(23)14721-3